-
Losartan 150 mg/day reduced left ventricular ejection fraction, intolerance to ACE inhibitors, and the rate of death and/or hospital admission for heart failure in patients with CHF more than did losartan 50 mg/day, thereby demonstrating the potential value of uptitrating ARB doses to confer clinical benefit.
-
-
The FDA has approved tranexamic acid, an antifibrinolytic drug, for the treatment of cyclic heavy menstrual bleeding.
-
Low-level lead intoxication, known to adversely affect young children's cognitive development and behavior, may also harm young adults.
-
Recurrent peptic ulcer bleeding was increased in patients with known cardiovascular or cerebrovascular disease when daily low-dose aspirin was continued along with proton-pump inhibitors, but overall mortality was significantly less during the 8-week follow-up.
-
When an older patient lies obliquely (at an angle) when asked to lie on a bed, he or she may be developing dementia.
-
The ECG above was obtained from a 24-year-old man with episodes of marked periodic weakness. He was otherwise healthy. What does the ECG suggest as a contributing cause of his symptoms? What disorder might the patient have?
-
High salt intake is associated with increased risk of stroke and heart disease.
-
-
Statin and niacin increase HDL-C, omeprazole reduces effectiveness of clopidogrel, darbe-poetin increases risk of stroke, statins decrease risk of gallstone disease, FDA Actions.